Repurposing Heparin as Antimalarial: Evaluation of Multiple Modifications Toward In Vivo Application
Heparin is a promising antimalarial drug due to its activity in inhibiting <i>Plasmodium</i> invasion of red blood cells and to the lack of resistance evolution by the parasite against it, but its potent anticoagulant activity is preventing the advance of heparin along the clinical pipel...
Saved in:
Main Authors: | Elena Lantero (Author), Carlos Raúl Aláez-Versón (Author), Pilar Romero (Author), Teresa Sierra (Author), Xavier Fernàndez-Busquets (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
by: Thomas R Lane, et al.
Published: (2019) -
An ImmunoPEGliposome for Targeted Antimalarial Combination Therapy at the Nanoscale
by: Arnau Biosca, et al.
Published: (2019) -
Structural modifications of quinoline-based antimalarial agents: Recent developments
by: Sandhya Bawa, et al.
Published: (2010) -
Surface Modification with NGF-Loaded Chitosan/Heparin Nanoparticles for Improving Biocompatibility of Cardiovascular Stent
by: Haixin Song, et al.
Published: (2021) -
Design, synthesis, and biological evaluation of multiple targeting antimalarials
by: Yiqing Yang, et al.
Published: (2021)